Try our beta test site
IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...
1 study found for:    NCT00351403
Show Display Options
Rank Status Study
1 Completed Individually Adapted Therapy Duration for the Treatment of Chronic Hepatitis C Genotype 1 Infection
Condition: Hepatitis C, Chronic
Interventions: Drug: Ribavirin;   Drug: Peginterferon alfa 2b

Study has passed its completion date and status has not been verified in more than two years.